Protocol summary

Study aim
Determining the effect of adding magnesium sulfate, dexmedetomidine and midazolam to bupivacaine with the caudal method in postoperative control of pain in 2-8 year old children who are candidates for lower abdominal surgery.
Design
Clinical trial, without control group, with three parallel groups, double-blind, randomized, phase 3 on 90 patients, for randomization, sealed envelope method is used.
Settings and conduct
The study will be conducted in Valiasr, Amir al-Mominin and Amir Kabir Arak hospitals. Randomization and then allocation of patients to the mentioned groups is done by the responsible anesthesia technician. Then the caudal anesthesia is performed by the anesthesiologist who only knows the drugs with labels on them.
Participants/Inclusion and exclusion criteria
The participants are children aged between 2 to 8 years old who are candidates for lower abdominal surgery. No emergency surgery or a surgery longer than 90 minutes is included; the participants are categorized as ASA classes I and II, have no previous history of hypersensitivity to the medications used in this study or suffer from renal, cardiac and congenital diseases. If a patient has to be multiple punctured, they are also omitted from the study.
Intervention groups
This study consists of three groups of 30 participants (total of 90 participants), that have been randomized in a double-blind fashion. The first group receives Bupivacaine(0.25%, 0.5 ml/kg) with Magnesium Sulfate(50 μg/kg), the second group receives Bupivacaine with Dexmedetomidine(1 μg/kg) and the third group receives Bupivacaine with Midazolam(50 μg/kg). Then the pain experienced by each group in analyzed with VAS and CHEOPS score.
Main outcome variables
VAS and CHEOPS score will be different among the three groups, the incident of vomiting, chills, additional analgesic consumption and vital signs might be different among three groups.

General information

Reason for update
Acronym
-
IRCT registration information
IRCT registration number: IRCT20240610062072N1
Registration date: 2024-06-22, 1403/04/02
Registration timing: registered_while_recruiting

Last update: 2024-06-22, 1403/04/02
Update count: 0
Registration date
2024-06-22, 1403/04/02
Registrant information
Name
Mitra Fazli
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 86 3422 4635
Email address
mitrafazli99@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-06-13, 1403/03/24
Expected recruitment end date
2025-02-12, 1403/11/24
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparing Magnesium Sulphate, Dexmedetomidine and Midazolam as adjuvant therapy to caudal Bupivacaine in postoperative analgesia in children undergoing lower abdominal surgery
Public title
Analgesia in children with lower abdominal surgery
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
All children between the ages of 2 to 8 years who are candidates for lower abdominal surgery Children who are candidates for lower abdominal surgery who are electively referred to Valiasr, Amir al-Momenin and Amir Kabir hospitals. Patients with ASA Class I, II Duration of surgery between 30 and 90 minutes Absence of seizure history, heart, lung, kidney and genetic diseases in patients who are candidates for surgery Absence of diseases and mental disorders and mental and physical decline Informed consent from the child's parents to participate in the study must be taken No sensitivity to local anesthetics
Exclusion criteria:
Patients who care candidates for emergency lower abdominal surgery Patients who are candidates for a surgery that lasts more than 90 minutes. Patients who suffer cardio-respiratory arrest during surgery for any reason. Patients who undergo multiple puncture in the process of caudal block.
Age
From 2 years old to 8 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Outcome assessor
  • Data analyser
  • Data and Safety Monitoring Board
Sample size
Target sample size: 90
Randomization (investigator's opinion)
Randomized
Randomization description
Patients are divided into three equal groups completely randomly and with a block pattern in the form of blocks of 6. Randomization is done using the online program at https://www.sealedenvelope.com/. Hiding the random chain is done by the method of opaque envelopes.
Blinding (investigator's opinion)
Double blinded
Blinding description
This study will be conducted in a double-blind manner. All children who are candidates for lower abdominal surgery, who are referred to the hospitals of Arak University of Medical Sciences as electives, and whose informed consent form is completed by their parents, are included in the study. Using blocks of six, they are divided into three equal groups completely randomly. There are 30 people in each group. Children are intubated by the anesthesia team after general anesthesia by the anesthesiologist. Then they are placed in lateral position and ready for caudal analgesia. Patients are divided into three groups A, B, C. The drugs that are supposed to be used for the caudal block are prepared in advance by the anesthesia technician and only A, B, C labels are placed on them. Then the caudal anesthesia is performed by the anesthesiologist who is the main investigator of the project and does not know the type of injectable drugs and only knows the drugs with labels on them. After the injection, the patient is supine, the surgery is performed, and then the project questionnaires will be filled in by the intern of the project, who does not know about the study groups. The division of patients into three groups A, B, and C and placing them in one of these three groups, in which they receive the desired drug according to their placement, is done by the anesthesiologist of the plan. Therefore, both the supervising anesthesiologist and the intern responsible for the design are both blinded to the groups.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
The Etihics Committe of Arak University of Medical Science
Street address
No. 6, Unit Eight, Amir Complex, Daneshsara Alley, Shariati St
City
Arak
Province
Markazi
Postal code
3813135518
Approval date
2024-06-09, 1403/03/20
Ethics committee reference number
IR.ARAKMU.REC.1403.083

Health conditions studied

1

Description of health condition studied
Repair of rectal prolapse, undescended testis, hypospadias repair, orchiopexy, inguinal hernia, hemorrhoids
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
The amount of postoperative pain in children undergoing lower abdominal surgery, which is measured by the Visual Analog Scale self-scoring tool or the Children's Hospital of Eastern Ontario Pain Scale descriptive tool.
Timepoint
The amount of pain is measured during recovery phase and then 2, 4, 8, 12 and 24 hours after the operation.
Method of measurement
Visual Analogue Scale tool is used for self-reporting of pain intensity. This criterion is easy to understand, its probability of error is low, and its filling time is short. It is used in all age groups and it is very easy for children to understand because of the smiling faces. The simplest type of Visual Analogue Scale measurement system is a straight line, usually 100 mm long. The investigated variable, which is pain, is lowest on the left side and highest on the right side. No pain from 0 to 4 mm, mild pain from 5 to 44 mm, moderate pain from 45 to 74 and severe pain from 75 to 100 mm. The scale line must be shown to the patient because it is a visual measure; In other words, they should be asked to indicate the extent of his pain on the line. Children's Hospital of Eastern Ontario Pain Scale, which stands for Children's Hospital of Eastern Ontario Pain Scale, is used to evaluate pain. This instrument measures six categories of pain-related behaviors in children aged 1 to 7 years: crying, face, speech, touch, legs, and upper body. A time period of 5 seconds is allocated to observe the child's behavior and 25 seconds to record the answer and score. The coordination between the clinical decision to start analgesic treatment with the results obtained from the Children's Hospital of Eastern Ontario Pain Scale criteria has the most understanding among the pain measurement criteria.

Secondary outcomes

1

Description
incidence of vomiting
Timepoint
During recovery and then 2, 4, 8, 12 and 24 hours after the operation
Method of measurement
A questionnaire designed for this study that raises the number of times shivering, vomiting, pain score and the degree of desire for extra analgesic and is filled by the intern.

2

Description
Incidence of chills
Timepoint
During recovery and then 2, 4, 8, 12 and 24 hours after the operation
Method of measurement
A questionnaire designed for this study that raises the number of times shivering, vomiting, pain score and the degree of desire for extra analgesic and is filled by the intern.

3

Description
Consumption of extra analgesic
Timepoint
During recovery and then 2, 4, 8, 12 and 24 hours after the operation
Method of measurement
Ward notes

4

Description
Blood pressure
Timepoint
During recovery and then 2, 4, 8, 12 and 24 hours after the operation
Method of measurement
Aneroid Sphygmomanometer or blood Pressure monitor

5

Description
Pulse rate
Timepoint
During recovery and then 2, 4, 8, 12 and 24 hours after the operation
Method of measurement
Pulse oximeter

6

Description
Blood Oxygen Saturation
Timepoint
During recovery and then 2, 4, 8, 12 and 24 hours after the operation
Method of measurement
Pulse oximeter

Intervention groups

1

Description
Intervention group 1: Patients are under general anesthesia with caudal block. Induction of anesthesia is done by inhalation with sevoflurane and oxygen. After establishing the intravenous route, atropine in the amount of 0.01 mg per kg and then atracorium in the amount of 0.5 mg per kg will be injected and tracheal intubation will be done. After induction of anesthesia, the patients will be placed in the lateral position and will receive Bupivacaine (0.25%, 0.5 ml/kg) along with magnesium sulfate (50 µg/kg) manufactured by Elixir inc. using a No. 22 needle. Patients will receive this combination only once. If the patient's pain requires more painkillers, acetaminophen tablets (10-15 mg/kg) can be used.
Category
Prevention

2

Description
Intervention group 2: Patients are under general anesthesia with caudal block. Induction of anesthesia is done by inhalation with sevoflurane and oxygen. After establishing the intravenous route, atropine in the amount of 0.01 mg per kg and then atracorium in the amount of 0.5 mg per kg will be injected and tracheal intubation will be done. After induction of anesthesia, the patients will be placed in the lateral position and will receive Bupivacaine (0.25%, 0.5 ml/kg) along with Dexmedetomidine(1 μg/kg) manufactured by Elixir inc. using a No. 22 needle. Patients will receive this combination only once. If the patient's pain requires more painkillers, acetaminophen tablets (10-15 mg/kg) can be used.
Category
Prevention

3

Description
Intervention group 3: Patients are under general anesthesia with caudal block. Induction of anesthesia is done by inhalation with sevoflurane and oxygen. After establishing the intravenous route, atropine in the amount of 0.01 mg per kg and then atracorium in the amount of 0.5 mg per kg will be injected and tracheal intubation will be done. After induction of anesthesia, the patients will be placed in the lateral position and will receive Bupivacaine (0.25%, 0.5 ml/kg) along with Midazolam(50 μg/kg) manufactured by Elixir inc. using a No. 22 needle. Patients will receive this combination only once. If the patient's pain requires more painkillers, acetaminophen tablets (10-15 mg/kg) can be used.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Vali-ye-Asr Hospital
Full name of responsible person
Alireza Kamali
Street address
Piroozie enghelab Ave, Vali-ye-asr intersection, Vali-ye-asr hospital
City
arak
Province
Markazi
Postal code
5755838149
Phone
+98 86 3222 2003
Email
pr_valieasr@arakmu.ac.ir

2

Recruitment center
Name of recruitment center
Amirkabir Hospital
Full name of responsible person
Alireza Kamali
Street address
Valiasr town, Nurses Square, Amirkabir Hospital
City
Arak
Province
Markazi
Postal code
3819691187
Phone
+98 86 3313 5075
Email
amirkabir-hospital@arakmu.ac.ir
Web page address
https://arakmu.ac.ir/amirkabirhos/fa

3

Recruitment center
Name of recruitment center
Amir Al Mo'menin Hospital
Full name of responsible person
Alireza Kamali
Street address
Sardash Street, Basij square, Amir Al Mo'menin Hospital
City
Arak
Province
Markazi
Postal code
3848176941
Phone
+98 86 3417 3601
Email
it-amiralmomenin@arakmu.ac.ir
Web page address
https://arakmu.ac.ir/amirhos/fa

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Alireza Kamali
Street address
Sardash Street, Basij square, Arak University of Medical Science
City
Arak
Province
Markazi
Postal code
3848176941
Phone
+98 86 3313 6055
Fax
+98 86 3417 3526
Email
info@arakmu.ac.ir
Web page address
https://www.arakmu.ac.ir/fa
Grant name
-
Grant code / Reference number
-
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Arak University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Mitra Fazli
Position
Intern
Latest degree
Medical doctor
Other areas of specialty/work
General Practitioner
Street address
Valiasar Square, Valiasr Hospital, education and research center
City
Arak
Province
Markazi
Postal code
38149 57558
Phone
+98 86 3422 4635
Fax
Email
mitrafazli99@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Mitra Fazli
Position
Intern
Latest degree
Medical doctor
Other areas of specialty/work
General Practitioner
Street address
Valiasar Square, Valiasr Hospital, Education and research center
City
Arak
Province
Markazi
Postal code
38149 57558
Phone
+98 86 3422 4635
Fax
Email
mitrafazli99@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Mitra Fazli
Position
Intern
Latest degree
Medical doctor
Other areas of specialty/work
General Practitioner
Street address
Valiasar Square, Valiasr Hospital, education and research center
City
Arak
Province
Markazi
Postal code
38149 57558
Phone
+98 86 3422 4635
Fax
Email
mitrafazli99@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
The personal data of the participants and their families will remain completely confidential, and only the information used in the data analysis including age, sex, the response to the medications used, and relevant reactions will be mentioned in the study.
When the data will become available and for how long
The study will take one year to be completed and the data will be available to the public between 6-9 months afterwards.
To whom data/document is available
Data and documentation will be available to universities, hospitals and scientific institutes. Send feedback
Under which criteria data/document could be used
The data at the level printed in the article will be available to scientific institutions and universities, but the private information of the patients will not be sent to any person or institution. The primary raw data and all of the measured variables may be made available to students and researchers upon request from the conducting researcher. The study can be used in systematic analysis, in review studies, in scientific proposals and as a reference in scientific articles and books.
From where data/document is obtainable
To get more information, including all measured variables and primary data, you can send a message to mitrafazli.md@gmail.com or WhatsApp on 09186293538.
What processes are involved for a request to access data/document
If you wish to access more information, email the author of the article Mitra Fazli via the E-mail, mitrafazli.md@gmail.com with the subject "Correspondence about the article comparing adjuvant treatments in the caudal block method in pediatric" by mentioning the academic rank and the purpose of further access. If a response isn't delivered within 2-4 weeks, send a message to WhatsApp via the phone number 09186293538. Phonecalls and SMS will not be answered.
Comments
Loading...